A drug discovery program starts when a disease or clinical condition has no suitable drugs. In response, the pharmaceutical industry and academic research groups can follow different processes aimed at identifying new molecules with drug-like properties that efficiently modulate the desired biological target. These new chemical entities can be isolated from natural sources or obtained by chemical synthesis, as demonstrated by the articles and review papers reported in this Special Issue.
Biological Activity of Natural and Synthetic Compounds
Granchi, Carlotta
Ultimo
2022-01-01
Abstract
A drug discovery program starts when a disease or clinical condition has no suitable drugs. In response, the pharmaceutical industry and academic research groups can follow different processes aimed at identifying new molecules with drug-like properties that efficiently modulate the desired biological target. These new chemical entities can be isolated from natural sources or obtained by chemical synthesis, as demonstrated by the articles and review papers reported in this Special Issue.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
molecules-27-03652.pdf
accesso aperto
Tipologia:
Versione finale editoriale
Licenza:
Creative commons
Dimensione
190.83 kB
Formato
Adobe PDF
|
190.83 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.